loader
Please Wait
Applying Filters...

Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Lucidinprimeveroside, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Lucidinprimeveroside

    DIGITAL CONTENT

    PharmaCompass

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    2D Structure
    1. Also known as: Lucidin primeveroside, 29706-59-0, Lucidin 3-o-primeveroside, 1-hydroxy-2-(hydroxymethyl)-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyanthracene-9,10-dione, Lucidin 3-o-beta-primveroside, 1-hydroxy-2-(hydroxymethyl)-3-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2s,3r,4s,5r)-3,4,5-trihydroxytetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl)oxy)anthracene-9,10-dione
    Molecular Formula
    C26H28O14
    Molecular Weight
    564.5  g/mol
    InChI Key
    NVKNRXOMCYTFJF-WFLOGZPDSA-N
    1-hydroxy-2-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}anthracene-9,10-dione is a natural product found in Rubia argyi, Rubia yunnanensis, and other organisms with data available.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    1-hydroxy-2-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyanthracene-9,10-dione
    2.1.2 InChI
    InChI=1S/C26H28O14/c27-6-12-14(5-11-16(19(12)31)18(30)10-4-2-1-3-9(10)17(11)29)39-26-24(36)22(34)21(33)15(40-26)8-38-25-23(35)20(32)13(28)7-37-25/h1-5,13,15,20-28,31-36H,6-8H2/t13-,15-,20+,21-,22+,23-,24-,25+,26-/m1/s1
    2.1.3 InChI Key
    NVKNRXOMCYTFJF-WFLOGZPDSA-N
    2.1.4 Canonical SMILES
    C1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(C(=C4C(=C3)C(=O)C5=CC=CC=C5C4=O)O)CO)O)O)O)O)O)O
    2.1.5 Isomeric SMILES
    C1[C@H]([C@@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(C(=C4C(=C3)C(=O)C5=CC=CC=C5C4=O)O)CO)O)O)O)O)O)O
    2.2 Synonyms
    2.2.1 MeSH Synonyms

    1. Lucidin 3-o-beta-primveroside

    2. Lucidin 3-o-primveroside

    2.2.2 Depositor-Supplied Synonyms

    1. Lucidin Primeveroside

    2. 29706-59-0

    3. Lucidin 3-o-primeveroside

    4. 1-hydroxy-2-(hydroxymethyl)-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyanthracene-9,10-dione

    5. Lucidin 3-o-beta-primveroside

    6. 1-hydroxy-2-(hydroxymethyl)-3-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2s,3r,4s,5r)-3,4,5-trihydroxytetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl)oxy)anthracene-9,10-dione

    7. 9,10-anthracenedione, 1-hydroxy-2-(hydroxymethyl)-3-[(6-o-beta-d-xylopyranosyl-beta-d-glucopyranosyl)oxy]-

    8. Ccris 4532

    9. Lucidin 3-o-primveroside

    10. Lucidin Primevoroside

    11. Lucidin-primeveroside

    12. Chembl521217

    13. Schembl23522435

    14. Dtxsid40952155

    15. Hy-n8022

    16. Zinc42878492

    17. Glucopyranoside, 4-hydroxy-3-(hydroxymethyl)-2-anthraquinonyl 6-o-beta-d- Xylopyranosyl-, Beta-d-

    18. Cs-0138995

    19. E88947

    20. 1-hydroxy-2-(hydroxymethyl)-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2s,3r,4s,5r)-3,4,5-trihydroxytetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-anthracene-9,10-dione

    21. 4-hydroxy-3-(hydroxymethyl)-9,10-dioxo-9,10-dihydroanthracen-2-yl 6-o-pentopyranosylhexopyranoside

    22. Ncgc00384986-01!1-hydroxy-2-(hydroxymethyl)-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyanthracene-9,10-dione

    2.3 Create Date
    2005-08-08
    3 Chemical and Physical Properties
    Molecular Weight 564.5 g/mol
    Molecular Formula C26H28O14
    XLogP3-2.1
    Hydrogen Bond Donor Count8
    Hydrogen Bond Acceptor Count14
    Rotatable Bond Count6
    Exact Mass564.14790556 g/mol
    Monoisotopic Mass564.14790556 g/mol
    Topological Polar Surface Area233 Ų
    Heavy Atom Count40
    Formal Charge0
    Complexity918
    Isotope Atom Count0
    Defined Atom Stereocenter Count9
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    Post Enquiry
    POST ENQUIRY